Effects of Ferrocene and Ferrocenium on MCF-7 Breast Cancer Cells and Interconnection with Regulated Cell Death Pathways.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
06 Sep 2023
Historique:
received: 19 07 2023
revised: 01 09 2023
accepted: 04 09 2023
medline: 4 10 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

The effects of ferrocene (

Identifiants

pubmed: 37764244
pii: molecules28186469
doi: 10.3390/molecules28186469
pmc: PMC10537025
pii:
doi:

Substances chimiques

ferrocenium 12125-80-3
ferrocene U96PKG90JQ
Metallocenes 0
Iron E1UOL152H7
Reactive Oxygen Species 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Control Release. 2022 Sep;349:617-633
pubmed: 35868357
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Curr Opin Chem Biol. 2015 Apr;25:172-83
pubmed: 25765750
J Cancer Res Clin Oncol. 1984;108(3):336-40
pubmed: 6511806
Cancer Cell. 2020 Aug 10;38(2):167-197
pubmed: 32649885
Pharmacol Rev. 2004 Jun;56(2):185-229
pubmed: 15169927
Sci Transl Med. 2010 Aug 4;2(43):43ra56
pubmed: 20686179
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Chem Soc Rev. 2015 Dec 21;44(24):8802-17
pubmed: 26486993
Curr Opin Chem Biol. 2020 Jun;56:28-34
pubmed: 31812831
J Med Chem. 2002 Dec 19;45(26):5786-96
pubmed: 12477361
Trends Mol Med. 2006 Sep;12(9):415-24
pubmed: 16890490
Analyst. 2014 Nov 21;139(22):5747-54
pubmed: 25270846
Cell Cycle. 2011 Dec 1;10(23):4047-64
pubmed: 22134189
J Biosci. 2003 Sep;28(5):581-8
pubmed: 14517361
Oxid Med Cell Longev. 2016;2016:4350965
pubmed: 26998193
Chem Sci. 2021 Nov 29;13(4):863-889
pubmed: 35211255
Exp Mol Med. 2020 Feb;52(2):192-203
pubmed: 32060354
J Med Chem. 2011 Jan 13;54(1):3-25
pubmed: 21077686
J Hematol Oncol. 2021 Jan 20;14(1):19
pubmed: 33472669
Blood. 2016 Jan 7;127(1):139-48
pubmed: 26463424
J Hematol Oncol. 2022 Dec 8;15(1):174
pubmed: 36482419
Chem Rev. 2004 Dec;104(12):5931-85
pubmed: 15584693
Biomed Pharmacother. 2022 Nov;155:113729
pubmed: 36166961
Nat Rev Mol Cell Biol. 2021 Apr;22(4):266-282
pubmed: 33495651
Free Radic Biol Med. 2010 Jan 1;48(1):120-7
pubmed: 19837156
Cancers (Basel). 2020 Sep 08;12(9):
pubmed: 32911610
Front Chem. 2022 Aug 11;10:967337
pubmed: 36034648
Free Radic Biol Med. 2021 Sep;173:29-40
pubmed: 34246777
J Drug Target. 2007 Aug-Sep;15(7-8):475-86
pubmed: 17671894
Antioxid Redox Signal. 2011 Aug 15;15(4):1085-127
pubmed: 21275772
Clin Biochem. 2012 Feb;45(3):231-6
pubmed: 22200561
Cell Death Dis. 2017 Mar 30;8(3):e2716
pubmed: 28358377
Mol Cell. 2012 Oct 26;48(2):158-67
pubmed: 23102266
J Proteome Res. 2010 Jun 4;9(6):2839-54
pubmed: 20408569
Dalton Trans. 2022 May 31;51(21):8085-8102
pubmed: 35583080
Nature. 2009 Apr 9;458(7239):780-3
pubmed: 19194462
Biomater Sci. 2023 Jan 17;11(2):542-553
pubmed: 36472166
Oncotarget. 2015 Feb 28;6(6):4330-44
pubmed: 25726526
Z Naturforsch C Biosci. 1985 Nov-Dec;40(11-12):843-6
pubmed: 3832667
Front Cell Dev Biol. 2021 Nov 29;9:765859
pubmed: 34912804
Cell Death Dis. 2021 Jan 11;12(1):65
pubmed: 33431801
Small. 2021 Aug;17(32):e2101368
pubmed: 34216420
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Front Cell Infect Microbiol. 2013 Sep 19;3:50
pubmed: 24066281
Biochim Biophys Acta. 2006 Mar;1760(3):301-9
pubmed: 16403600
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Mol Cancer. 2022 Feb 12;21(1):47
pubmed: 35151318
Microb Biotechnol. 2021 Jan;14(1):111-125
pubmed: 33124755
Acc Chem Res. 2013 Feb 19;46(2):550-9
pubmed: 23157446
Curr Opin Chem Biol. 2012 Apr;16(1-2):84-91
pubmed: 22366385
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
Nat Rev Mol Cell Biol. 2022 Jul;23(7):499-515
pubmed: 35190722
Eur J Med Chem. 2018 Jul 15;155:459-482
pubmed: 29908440
Mol Cancer. 2019 May 23;18(1):100
pubmed: 31122251

Auteurs

Cristina Favaron (C)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Via Ferrata 9, 27100 Pavia, Italy.

Elisabetta Gabano (E)

Department of Sustainable Development and Ecological Transition, University of Piemonte Orientale, Piazza S. Eusebio 5, 13100 Vercelli, Italy.

Ilaria Zanellato (I)

Department of Sciences and Technological Innovation, University of Piemonte Orientale, Viale Teresa Michel 11, 15121 Alessandria, Italy.

Ludovica Gaiaschi (L)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Via Ferrata 9, 27100 Pavia, Italy.

Claudio Casali (C)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Via Ferrata 9, 27100 Pavia, Italy.

Maria Grazia Bottone (MG)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Via Ferrata 9, 27100 Pavia, Italy.

Mauro Ravera (M)

Department of Sciences and Technological Innovation, University of Piemonte Orientale, Viale Teresa Michel 11, 15121 Alessandria, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH